Stay Curious

SIGN UP FOR OUR WEEKLY NEWSLETTER AND UNLOCK ONE MORE ARTICLE FOR FREE.

Sign Up

VIEW OUR Privacy Policy


Discover Magazine Logo

WANT MORE? KEEP READING FOR AS LOW AS $1.99!

Subscribe

ALREADY A SUBSCRIBER?

FIND MY SUBSCRIPTION
Advertisement

This Is Your Brain on Smoke

Research shows smokers have a lower risk of developing Parkinson’s disease due to reduced levels of the enzyme monoamine oxidase B.

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

Over the past few years, several studies have found that people who smoke have about half the risk that nonsmokers have of developing Parkinson’s disease. Last February researchers reported a possible reason for this strange link: an enzyme called monoamine oxidase B (mao B). mao B is one of the enzymes involved in breaking down the neurotransmitter dopamine, which the brain uses when it creates and controls movement. Because people with Parkinson’s have unusually low levels of dopamine, they suffer from uncontrollable tremors, rigid muscles, and difficulty walking and talking.

Chemist Joanna Fowler and her colleagues at Brookhaven National Laboratory in Upton, New York, pet-scanned the brains of eight smokers, eight nonsmokers, and four former smokers. They found that mao B levels in the smokers’ brains were 40 percent lower than in the other two groups. If you have less mao B, the researchers speculate, then you’ll have more available ...

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe
Advertisement

0 Free Articles